BIENAIME JEAN JACQUES Insider Trading
Get the latest insider transactions of BIENAIME JEAN JACQUES. BIENAIME JEAN JACQUES is Director in INCYTE CORP ($INCY) and Chief Executive Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in VITAL THERAPIES INC ($VTL). Discover the current value of BIENAIME JEAN JACQUES shares.
Address:
BIENAIME JEAN JACQUES is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
BMRN | BIOMARIN PHARMACEUTICAL INC | Chief Executive Officer | 304,839 | 27,103,235.49 |
VTL | IMMUNIC, INC. | Director | 18,500 | 86,025.00 |
INCY | INCYTE CORP | Director | 8,921 | 1,054,283.78 |
Insider Trading Transactions of BIENAIME JEAN JACQUES
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 37.46 | 1,000 | 37,460 | 304,839 |
Jun 23 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 37.46 | 1,000 | 37,460 | 138,000 |
May 12 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 8,513 | 225,509 | 312,352 |
May 12 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 77.29 | 8,513 | 657,970 | 303,839 |
May 12 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 8,513 | 225,509 | 0 |
May 10 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 62.41 | 341 | 21,281 | 303,839 |
May 10 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 25,000 | 662,250 | 328,839 |
May 10 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 78.01 | 14,825 | 1,156,528 | 314,014 |
May 10 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 78.69 | 10,175 | 800,671 | 303,839 |
May 10 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 25,000 | 662,250 | 328,839 |
May 10 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 77.60 | 15,556 | 1,207,146 | 313,283 |
May 10 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 78.77 | 6,115 | 481,672 | 307,168 |
May 10 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 79.39 | 3,329 | 264,303 | 303,839 |
May 10 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 25,000 | 662,250 | 33,513 |
May 10 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 25,000 | 662,250 | 8,513 |
May 03 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 37.46 | 1,000 | 37,460 | 303,498 |
May 03 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 37.46 | 1,000 | 37,460 | 139,000 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 10,000 | 264,900 | 312,498 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 78.91 | 10,000 | 789,100 | 302,498 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 10,000 | 264,900 | 312,498 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 10,000 | 264,900 | 312,498 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 78.91 | 10,000 | 789,100 | 302,498 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 79.34 | 10,000 | 793,400 | 302,498 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 10,000 | 264,900 | 312,498 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 10,000 | 264,900 | 68,513 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 79.34 | 10,000 | 793,400 | 302,498 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 10,000 | 264,900 | 58,513 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 10,000 | 264,900 | 68,513 |
Apr 26 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 10,000 | 264,900 | 58,513 |
Mar 23 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 78.52 | 5,519 | 433,352 | 302,498 |
Mar 17 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 0.00 | 41,350 | 0 | 337,002 |
Mar 17 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 78.39 | 23,426 | 1,836,364 | 313,576 |
Mar 17 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 77.21 | 5,559 | 429,210 | 308,017 |
Mar 17 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 78.39 | 101,820 | 7,981,670 | 101,820 |
Mar 15 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 77.94 | 100 | 7,794 | 295,652 |
Mar 15 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 7,000 | 185,430 | 302,652 |
Mar 15 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 77.68 | 7,000 | 543,760 | 295,652 |
Mar 15 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 7,000 | 185,430 | 302,652 |
Mar 15 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 77.10 | 7,000 | 539,700 | 295,652 |
Mar 15 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 7,000 | 185,430 | 85,513 |
Mar 15 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 7,000 | 185,430 | 78,513 |
Feb 22 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 7,000 | 185,430 | 302,552 |
Feb 22 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 83.58 | 7,000 | 585,060 | 295,552 |
Feb 22 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 7,000 | 185,430 | 92,513 |
Feb 19 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 7,000 | 185,430 | 302,552 |
Feb 19 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 85.08 | 7,000 | 595,560 | 295,552 |
Feb 19 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 7,000 | 185,430 | 99,513 |
Feb 18 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 8,000 | 211,920 | 303,552 |
Feb 18 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 84.54 | 8,000 | 676,320 | 295,552 |
Feb 18 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 8,000 | 211,920 | 106,513 |
Feb 01 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 8,333 | 220,741 | 303,885 |
Feb 01 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 82.91 | 8,333 | 690,889 | 295,552 |
Feb 01 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 8,334 | 220,768 | 303,886 |
Feb 01 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 82.67 | 8,334 | 688,972 | 295,552 |
Feb 01 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 8,333 | 220,741 | 122,847 |
Feb 01 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 8,334 | 220,768 | 114,513 |
Jan 28 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 8,333 | 220,741 | 303,885 |
Jan 28 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 85.49 | 8,333 | 712,388 | 295,552 |
Jan 28 2021 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 8,333 | 220,741 | 131,180 |
Jan 05 2021 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | 86.98 | 275 | 23,920 | 8,921 |
Jan 05 2021 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | 86.98 | 275 | 23,920 | 8,921 |
Dec 30 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 0.00 | 425 | 0 | 247,533 |
Dec 30 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 88.77 | 1,500 | 133,155 | 297,052 |
Dec 30 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 88.18 | 1,500 | 132,270 | 295,552 |
Nov 12 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Sell | 83.00 | 798 | 66,234 | 8,646 |
Nov 12 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Sell | 83.00 | 798 | 66,234 | 8,646 |
Oct 01 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | 89.74 | 254 | 22,794 | 9,444 |
Jul 01 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | 103.97 | 208 | 21,626 | 9,190 |
May 28 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | 0.00 | 1,282 | 0 | 8,982 |
May 28 2020 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Option Exercise | 98.68 | 10,514 | 1,037,522 | 10,514 |
May 12 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 20,000 | 430,200 | 318,552 |
May 12 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 91.72 | 20,000 | 1,834,400 | 298,552 |
May 12 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 20,000 | 430,200 | 0 |
May 05 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 62.59 | 339 | 21,217 | 298,552 |
May 05 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 4,000 | 86,040 | 302,552 |
May 05 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 89.38 | 4,000 | 357,520 | 298,552 |
May 05 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 5,000 | 107,550 | 303,552 |
May 05 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 88.00 | 5,000 | 440,000 | 298,552 |
May 05 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 4,000 | 86,040 | 25,000 |
May 05 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 5,000 | 107,550 | 20,000 |
Apr 29 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 20,000 | 430,200 | 318,213 |
Apr 29 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 97.73 | 20,000 | 1,954,600 | 298,213 |
Apr 29 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 20,000 | 430,200 | 318,213 |
Apr 29 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 97.58 | 20,000 | 1,951,600 | 298,213 |
Apr 29 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 20,000 | 430,200 | 49,000 |
Apr 29 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 20,000 | 430,200 | 29,000 |
Apr 13 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 10,000 | 215,100 | 308,213 |
Apr 13 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 79.06 | 10,000 | 790,600 | 298,213 |
Apr 13 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 10,000 | 215,100 | 69,000 |
Apr 08 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 1,000 | 26,490 | 298,213 |
Apr 08 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 1,000 | 26,490 | 139,513 |
Apr 08 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 26.49 | 1,000 | 26,490 | 298,213 |
Apr 08 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 26.49 | 1,000 | 26,490 | 139,513 |
Mar 24 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 73.05 | 13,128 | 959,000 | 297,213 |
Mar 17 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 84.50 | 30,952 | 2,615,444 | 265,491 |
Mar 17 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 0.00 | 44,850 | 0 | 310,341 |
Mar 17 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 73.82 | 127,920 | 9,443,054 | 127,920 |
Mar 11 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 94.39 | 30 | 2,832 | 296,443 |
Mar 11 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 10,000 | 215,100 | 306,443 |
Mar 11 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 89.52 | 10,000 | 895,200 | 296,443 |
Mar 11 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 10,000 | 215,100 | 79,000 |
Mar 04 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 0.00 | 35,580 | 0 | 296,413 |
Feb 05 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 10,000 | 215,100 | 338,530 |
Feb 05 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 83.50 | 10,000 | 835,000 | 328,530 |
Feb 05 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 10,000 | 215,100 | 89,000 |
Feb 03 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 1,000 | 21,510 | 328,530 |
Feb 03 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 1,000 | 21,510 | 99,000 |
Jan 16 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 8,000 | 172,080 | 335,530 |
Jan 16 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 87.95 | 8,000 | 703,600 | 327,530 |
Jan 16 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 8,000 | 172,080 | 100,000 |
Jan 16 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 8,000 | 172,080 | 335,530 |
Jan 16 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 87.95 | 8,000 | 703,600 | 327,530 |
Jan 16 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 8,000 | 172,080 | 100,000 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 3,000 | 64,530 | 330,530 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 84.46 | 3,000 | 253,380 | 327,530 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 4,000 | 86,040 | 331,530 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 84.92 | 4,000 | 339,680 | 327,530 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 3,000 | 64,530 | 330,530 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 3,000 | 64,530 | 112,000 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 84.46 | 3,000 | 253,380 | 327,530 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 4,000 | 86,040 | 108,000 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 4,000 | 86,040 | 331,530 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 84.92 | 4,000 | 339,680 | 327,530 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 3,000 | 64,530 | 112,000 |
Jan 09 2020 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 4,000 | 86,040 | 108,000 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 3,000 | 64,530 | 330,530 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 86.43 | 3,000 | 259,290 | 327,530 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 5,000 | 107,550 | 332,530 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 86.16 | 5,000 | 430,800 | 327,530 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 0.00 | 630 | 0 | 180,261 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 3,000 | 64,530 | 120,000 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 5,000 | 107,550 | 115,000 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 3,000 | 64,530 | 330,530 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 86.43 | 3,000 | 259,290 | 327,530 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 5,000 | 107,550 | 332,530 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 86.16 | 5,000 | 430,800 | 327,530 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 0.00 | 630 | 0 | 180,261 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 3,000 | 64,530 | 120,000 |
Dec 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 5,000 | 107,550 | 115,000 |
Nov 26 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 0.00 | 450 | 0 | 327,070 |
Nov 26 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 75.38 | 10 | 754 | 327,080 |
Nov 26 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 10,000 | 215,100 | 337,080 |
Nov 26 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 77.60 | 10,000 | 776,000 | 327,080 |
Nov 26 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 6,000 | 129,060 | 127,000 |
Nov 26 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 4,000 | 86,040 | 123,000 |
Oct 29 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 5,000 | 107,550 | 332,520 |
Oct 29 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 69.55 | 5,000 | 347,750 | 327,520 |
Oct 29 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 5,000 | 107,550 | 133,000 |
Oct 02 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | 74.23 | 219 | 16,256 | 7,274 |
Oct 02 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | 74.23 | 219 | 16,256 | 7,274 |
Sep 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 1,000 | 21,510 | 327,520 |
Sep 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 1,000 | 21,510 | 327,520 |
Sep 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 1,000 | 21,510 | 138,000 |
Sep 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 1,000 | 21,510 | 138,000 |
Aug 05 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Sell | 85.16 | 1,347 | 114,711 | 7,432 |
Aug 05 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Sell | 84.73 | 377 | 31,943 | 7,055 |
May 14 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 10,000 | 143,900 | 336,520 |
May 14 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 82.52 | 10,000 | 825,193 | 326,520 |
May 14 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 10,000 | 143,900 | 0 |
May 13 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 330,520 |
May 13 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 81.97 | 4,000 | 327,888 | 326,520 |
May 13 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 10,000 |
May 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 68.78 | 309 | 21,254 | 326,520 |
May 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 330,520 |
May 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 82.16 | 4,000 | 328,625 | 326,520 |
May 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 14,000 |
Apr 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 3,000 | 43,170 | 329,211 |
Apr 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 82.44 | 2,000 | 164,889 | 327,211 |
Apr 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 83.59 | 800 | 66,870 | 326,411 |
Apr 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 84.41 | 200 | 16,881 | 326,211 |
Apr 30 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 3,000 | 43,170 | 18,000 |
Apr 29 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | 0.00 | 1,520 | 0 | 8,584 |
Apr 29 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Option Exercise | 75.03 | 12,472 | 935,774 | 12,472 |
Apr 18 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 21.51 | 1,000 | 21,510 | 326,211 |
Apr 18 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 21.51 | 1,000 | 21,510 | 139,000 |
Apr 15 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 1,000 | 14,390 | 325,211 |
Apr 15 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 329,211 |
Apr 15 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 89.12 | 4,000 | 356,480 | 325,211 |
Apr 15 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 1,000 | 14,390 | 25,000 |
Apr 15 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 21,000 |
Apr 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 3,000 | 43,170 | 327,211 |
Apr 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 93.37 | 3,000 | 280,114 | 324,211 |
Apr 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 3,000 | 43,170 | 29,000 |
Apr 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 3,000 | 43,170 | 327,211 |
Apr 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 91.27 | 2,200 | 200,787 | 325,011 |
Apr 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 92.39 | 100 | 9,239 | 324,911 |
Apr 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 93.67 | 700 | 65,572 | 324,211 |
Apr 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 3,000 | 43,170 | 29,000 |
Apr 02 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | 86.01 | 168 | 14,450 | 7,064 |
Mar 29 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 1,000 | 14,390 | 324,211 |
Mar 29 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 1,000 | 14,390 | 32,000 |
Mar 26 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 88.05 | 13,127 | 1,155,832 | 323,211 |
Mar 26 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 327,211 |
Mar 26 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 87.86 | 4,000 | 351,440 | 323,211 |
Mar 26 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 33,000 |
Mar 21 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 1,000 | 14,390 | 336,338 |
Mar 21 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 1,000 | 14,390 | 37,000 |
Mar 19 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 94.53 | 28,143 | 2,660,358 | 300,558 |
Mar 19 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 0.00 | 34,780 | 0 | 335,338 |
Mar 19 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 339,338 |
Mar 19 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 94.40 | 4,000 | 377,600 | 335,338 |
Mar 19 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 94.53 | 87,080 | 8,231,672 | 87,080 |
Mar 19 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 38,000 |
Mar 14 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 3,000 | 43,170 | 331,701 |
Mar 14 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 93.42 | 3,000 | 280,253 | 328,701 |
Mar 14 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 3,000 | 43,170 | 42,000 |
Mar 13 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 5,000 | 71,950 | 333,701 |
Mar 13 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 88.96 | 5,000 | 444,780 | 328,701 |
Mar 13 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 332,701 |
Mar 13 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 91.44 | 4,000 | 365,770 | 328,701 |
Mar 13 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 5,000 | 71,950 | 49,000 |
Mar 13 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 45,000 |
Mar 08 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 332,701 |
Mar 08 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 332,701 |
Mar 08 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 90.78 | 4,000 | 363,120 | 328,701 |
Mar 08 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 90.78 | 4,000 | 363,120 | 328,701 |
Mar 08 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 54,000 |
Mar 08 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 54,000 |
Mar 05 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 0.00 | 45,320 | 0 | 333,610 |
Mar 05 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 94.76 | 4,909 | 465,177 | 328,701 |
Feb 28 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 292,290 |
Feb 28 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 91.78 | 4,000 | 367,120 | 288,290 |
Feb 28 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 58,000 |
Feb 22 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 3,000 | 43,170 | 291,290 |
Feb 22 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 90.12 | 3,000 | 270,360 | 288,290 |
Feb 22 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 3,000 | 43,170 | 62,000 |
Feb 15 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 292,290 |
Feb 15 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 95.20 | 4,000 | 380,800 | 288,290 |
Feb 15 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 65,000 |
Feb 07 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 292,290 |
Feb 07 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 98.63 | 4,000 | 394,520 | 288,290 |
Feb 07 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 69,000 |
Jan 24 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 3,000 | 43,170 | 291,290 |
Jan 24 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 96.82 | 3,000 | 290,460 | 288,290 |
Jan 24 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 3,000 | 43,170 | 73,000 |
Jan 15 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 4,000 | 57,560 | 292,290 |
Jan 15 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 93.79 | 4,000 | 375,160 | 288,290 |
Jan 15 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 4,000 | 57,560 | 76,000 |
Jan 11 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 3,000 | 43,170 | 291,290 |
Jan 11 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 90.55 | 3,000 | 271,650 | 288,290 |
Jan 11 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 3,000 | 43,170 | 80,000 |
Jan 10 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 6,000 | 86,340 | 294,290 |
Jan 10 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 91.14 | 1,000 | 91,144 | 293,290 |
Jan 10 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 91.55 | 1,599 | 146,388 | 291,691 |
Jan 10 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 91.73 | 3,401 | 311,990 | 288,290 |
Jan 10 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 6,000 | 86,340 | 83,000 |
Jan 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Buy | 14.39 | 3,000 | 43,170 | 291,290 |
Jan 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Sell | 87.58 | 3,000 | 262,740 | 288,290 |
Jan 09 2019 | BMRN | BIOMARIN PHARMACEUTICAL I ... | BIENAIME JEAN JACQUES | Chief Executive Offic ... | Option Exercise | 14.39 | 3,000 | 43,170 | 89,000 |
Jan 03 2019 | INCY | INCYTE CORP | BIENAIME JEAN JACQUES | Director | Buy | 63.59 | 228 | 14,499 | 6,896 |